“Tirzepatide” has been added to your cart.
View cart
Showing 17–19 of 19 results
-
$75.00
Codename: The Sculptor
Mission Type: GH Secretagogue / Fat Reduction
Mission Overview
Tesamorelin is a growth hormone–releasing agent engineered to reduce resistant visceral fat while simultaneously elevating natural GH output. This is the operative you deploy when the mission calls for recompisition and restoration.
Tactical Advantages
-
Visceral fat reduction: Specifically targets dangerous belly fat stores.
-
GH surge: Stimulates natural growth hormone production.
-
Metabolic support: Improves insulin sensitivity & nutrient utilization.
-
Anti-aging intel: Supports cognition, sleep quality, and body composition.
Intel Report
-
Mission timeframe: Effects build with consistent deployment over weeks, patience required.
-
Improves recovery, sleep, and lean tissue preservation.
-
Clinical origins: Developed for HIV-related lipodystrophy, now utilized tactically for body comp.
Arsenal Deployment
-
Most effective when paired with dietary discipline and conditioning work.
-
Stack with RETA for cutting-edge fat-loss synergy.
-
Combine with L-Carnitine to amplify fat mobilization.
For Research Use Only. Not for Human Consumption.
-
$335.00
Dual GIP/GLP-1 Receptor Agonist | Metabolic Research Peptide | For Laboratory Use Only
Overview Tirzepatide is a next-generation dual incretin agonist that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. Researchers study this molecule for its powerful role in metabolic regulation, appetite signaling, glucose control, and body-composition pathways.
Because of its dual-pathway mechanism, Tirzepatide is frequently selected for research exploring advanced strategies for metabolic optimization and multi-hormonal modulation.
-
BPC-157 + TB-500 (10mg/10mg) — Wolverine Duo
Research Peptide Blend | 20mg Total | For Laboratory Use Only
Overview
The BPC-157 + TB-500 combo is one of the most sought-after research pairings in the recovery space. Formulated with 10mg of BPC-157 and 10mg of TB-500, this dual-peptide solution supports studies exploring accelerated tissue repair, reduced inflammation, enhanced mobility, and optimized recovery pathways.
Engineered for researchers who demand efficiency and synergy, this combination allows targeted investigation into how these peptides may work together across muscle, tendon, ligament, and soft-tissue models.
